AGEN (Agenus Inc) Gross Profit Margin

AGEN (Agenus, Inc.) - company brandmark

Agenus develops innovative vaccines and targeted cancer therapies, focusing on immune checkpoints. Quarterly gross margins demonstrate effective cost management, where the 98.40 level represents the current figure. However, fierce competition with corporate behemoths for a place in treatment protocols creates risks. Due to a lack of funds, Agenus is actively seeking strategic partners for the joint development of molecules.

AGEN - Agenus Return on Gross Profit over the range 07/04/2022 - 11/19/2026

Financial and market metric breakdowns for Agenus, Inc (AGEN)

- market price and analyst price targets:
- business market valuation indicators:
Fundamental valuation:AGEN (Agenus Inc.)
Mass-produced product of Agenus Inc

Agenus strategic alliances in immunopharmaceuticals and the joint development of targeted vaccines directly impact current gross margin dynamics. This indicator measures the portion of revenue remaining after deducting direct production costs, allowing investors to assess cost management efficiency and the company's fundamental capital stability when bringing innovative products to market.

Direct competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability